J Clin Periodontol: 唾液和血清标志物在牙周炎和冠心病中的应用

2018-09-10 MedSci MedSci原创

基质金属蛋白酶(MMP)-8,MMP-9,基质金属蛋白酶组织抑制剂(TIMP)-1和髓过氧化物酶(MPO)参与牙周组织和动脉粥样硬化斑块的细胞外基质分解。我们调查了血清和唾液生物标志物在牙周炎和急性冠状动脉综合征(ACS)中的诊断价值。

基质金属蛋白酶(MMP)-8,MMP-9,基质金属蛋白酶组织抑制剂(TIMP)-1和髓过氧化物酶(MPO)参与牙周组织和动脉粥样硬化斑块的细胞外基质分解。我们调查了血清和唾液生物标志物在牙周炎和急性冠状动脉综合征(ACS)中的诊断价值。

人群为PAROGENE(n = 481),随机队列的患者均有冠状动脉造影指征。所有患者均接受了临床和影像学口腔检查。比较由牙周炎与非牙周炎和ACS与非ACS患者组成的几个组。

结果:唾液MMP-8,MMP-9和MPO对牙周炎提供显着的曲线下面积(AUC)值,分别为0.69(<0.001),0.66(<0.001)和0.68(<0.001)。血清MMP-8,MMP-9和MPO水平区分ACS与非ACS患者的AUC分别为0.73(<0.001),0.58(0.03)和0.68(<0.001)。牙周炎混淆了血清MMP-9在ACS诊断中的应用。心脏状态使唾液TIMP-1在牙周诊断中的使用变得复杂。唾液生物标志物不能用于ACS诊断,血清生物标志物不能用于诊断牙周炎。

MMP-8,MMP-9,TIMP-1和MPO是ACS和牙周炎的重要生物标志物,但样本来源至关重要。血清适合ACS诊断,唾液适用于牙周诊断。

原始出处:

Laura S. J. Lahdentausta, et al.Saliva and serum biomarkers in periodontitis and coronary artery disease. Journal of Clinical Periodontology. 2018 September. doi:10.1111/jcpe.12976

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1841293, encodeId=93f21841293a4, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun May 12 00:37:00 CST 2019, time=2019-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727579, encodeId=f4131e2757937, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Sep 25 08:37:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704071, encodeId=fe251e04071c0, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89405, encryptionId=f407894051e, topicName=血清标志物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de7930650164, createdName=jichang, createdTime=Sat Jan 05 14:37:00 CST 2019, time=2019-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451002, encodeId=72b21451002e7, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Sep 12 12:37:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344415, encodeId=ce083444153e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Sep 10 22:04:38 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1841293, encodeId=93f21841293a4, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun May 12 00:37:00 CST 2019, time=2019-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727579, encodeId=f4131e2757937, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Sep 25 08:37:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704071, encodeId=fe251e04071c0, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89405, encryptionId=f407894051e, topicName=血清标志物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de7930650164, createdName=jichang, createdTime=Sat Jan 05 14:37:00 CST 2019, time=2019-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451002, encodeId=72b21451002e7, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Sep 12 12:37:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344415, encodeId=ce083444153e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Sep 10 22:04:38 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2018-09-25 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1841293, encodeId=93f21841293a4, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun May 12 00:37:00 CST 2019, time=2019-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727579, encodeId=f4131e2757937, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Sep 25 08:37:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704071, encodeId=fe251e04071c0, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89405, encryptionId=f407894051e, topicName=血清标志物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de7930650164, createdName=jichang, createdTime=Sat Jan 05 14:37:00 CST 2019, time=2019-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451002, encodeId=72b21451002e7, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Sep 12 12:37:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344415, encodeId=ce083444153e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Sep 10 22:04:38 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1841293, encodeId=93f21841293a4, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun May 12 00:37:00 CST 2019, time=2019-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727579, encodeId=f4131e2757937, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Sep 25 08:37:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704071, encodeId=fe251e04071c0, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89405, encryptionId=f407894051e, topicName=血清标志物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de7930650164, createdName=jichang, createdTime=Sat Jan 05 14:37:00 CST 2019, time=2019-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451002, encodeId=72b21451002e7, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Sep 12 12:37:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344415, encodeId=ce083444153e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Sep 10 22:04:38 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1841293, encodeId=93f21841293a4, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun May 12 00:37:00 CST 2019, time=2019-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727579, encodeId=f4131e2757937, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Sep 25 08:37:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704071, encodeId=fe251e04071c0, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89405, encryptionId=f407894051e, topicName=血清标志物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de7930650164, createdName=jichang, createdTime=Sat Jan 05 14:37:00 CST 2019, time=2019-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1451002, encodeId=72b21451002e7, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Sep 12 12:37:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344415, encodeId=ce083444153e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Sep 10 22:04:38 CST 2018, time=2018-09-10, status=1, ipAttribution=)]
    2018-09-10 医者仁心5538

    学习了

    0

相关资讯

Int J Oral Max Surg:口腔鳞状细胞癌患者唾液和血浆中细胞因子生物标志物

这项研究的目的是调查人类唾液和血浆中潜在的生物标志物,以帮助早期诊断口腔鳞状细胞癌(OSCC)。

新方法!通过唾液提前检测免疫系统疾病

临床试验显示,病人可以在症状出现前,就通过唾液检测了解自己患病的情况,从而增加康复的机会。

J Clin Periodontol: 唾液生物标志物exRNA用于检测牙龈炎及疾病消退

这项研究旨在测试唾液细胞外RNA(exRNA)生物标记物是否可用于检测牙龈炎和监测疾病消除。

Allergol Int:在季节过敏性鼻炎中,全唾液在舌下免疫治疗效果中的作用研究

开发能够预测舌下免疫治疗(SLIT)治疗过敏性疾病临床效果的方法是一个非常关键的问题。全唾液作为SLIT治疗中与过敏原提取物首先接触的组分,最近,有研究人员在日本柳杉花粉过敏症中,探究了是否全唾液与SLIT的临床效果相关。研究人员将血液单核细胞或者单核THP-1细胞培养在含有或者不含油全唾液或者纯唾液的培养基中,并且还包括或者不包括唾液过滤和TLR2和/或TLR4信号的阻断处理。研究发现,单核细胞

J Periodontol: Annexin-1是否可用作妊娠期牙龈炎唾液生物标志物

已知,怀孕期间患者易患牙龈炎。膜联蛋白-1(ANXA1)是一种抗炎蛋白,已通过蛋白质组学,在牙龈组织分泌物中发现。该横断面病例对照研究的目的是调查ANXA1和促炎介质白细胞介素(IL)-1β在妊娠和未妊娠妇女唾液中的水平和关联。

PLoS One:从唾液微生物谱看全身疾病

唾液分析正在成为诊断和监测疾病的一种有前途的工具,这使得在不同情况下确定唾液微生物的分布变得至关重要。本研究旨在评估年龄,牙周病,性别,吸烟和医疗条件对唾液微生物特征的影响。 随机抽取441人样本(51%为女性,平均年龄48.5±16.8)。参与者回答健康问卷并接受口腔检查。收集刺激条件下的唾液并通过棋盘DNA-DNA杂交确定41种细菌的计数。 结果显示,与成年人(≤64岁)相比,老年